QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)

Pharmaceutical Stocks List

Compare pharmaceutical stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Learn more about trading pharmaceutical stocks.

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Moderna, Inc. stock logo
MRNA
Moderna
$125.33
-0.2%
$143.39
$115.03
$217.25
$47.78 B1.73.55 million shs2.99 million shs
AbbVie Inc. stock logo
ABBV
AbbVie
$143.44
+0.1%
$155.31
$134.09
$168.11
$253.07 B0.585.89 million shs4.76 million shs
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$65.70
-1.2%
$68.43
$65.18
$81.43
$138.03 B0.448.05 million shs10.05 million shs
GSK plc stock logo
GSK
GSK
$35.21
-1.6%
$36.04
$28.47
$45.14
$72.09 B0.673.38 million shs3.26 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$158.48
-0.3%
$159.41
$150.11
$183.35
$411.85 B0.537.74 million shs5.17 million shs
McKesson Co. stock logo
MCK
McKesson
$397.86
-0.8%
$360.79
$298.69
$401.78
$53.95 B0.58995,552 shs748,602 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$114.00
-0.7%
$111.97
$83.05
$119.65
$289.27 B0.347.89 million shs6.43 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$36.48
-0.7%
$39.79
$36.17
$54.93
$205.94 B0.6322.55 million shs27.27 million shs
XPH
SPDR S&P Pharmaceuticals ETF
$40.55
-0.5%
$41.39
$38.18
$44.84
$186.53 M0.8456,817 shs35,956 shs

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Moderna, Inc. stock logo
MRNA
Moderna
+0.37%-4.02%-12.78%-27.13%-11.74%
AbbVie Inc. stock logo
ABBV
AbbVie
+0.04%-2.10%-11.06%-4.13%-7.38%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-0.73%-2.86%-5.76%-6.10%-14.95%
GSK plc stock logo
GSK
GSK
-0.90%-1.07%-3.34%+2.85%-19.17%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.22%-1.65%-4.03%+0.47%-11.09%
McKesson Co. stock logo
MCK
McKesson
+1.24%+1.65%+10.37%+10.23%+20.35%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-1.14%-2.66%-0.22%+7.75%+23.40%
Pfizer Inc. stock logo
PFE
Pfizer
-0.70%-4.05%-10.76%-14.44%-28.42%
XPH
SPDR S&P Pharmaceuticals ETF
-0.22%-3.85%-3.64%-4.05%-2.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Moderna, Inc. stock logo
MRNA
Moderna
2.6877 of 5 stars
4.21.00.04.62.93.31.3
AbbVie Inc. stock logo
ABBV
AbbVie
2.6995 of 5 stars
2.23.04.23.93.12.51.9
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.6046 of 5 stars
2.23.04.24.03.22.51.3
GSK plc stock logo
GSK
GSK
2.0886 of 5 stars
0.03.03.30.02.40.01.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.8429 of 5 stars
2.25.03.33.93.32.51.9
McKesson Co. stock logo
MCK
McKesson
2.3402 of 5 stars
1.43.03.33.02.42.52.5
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
3.2123 of 5 stars
2.35.04.24.03.12.53.1
Pfizer Inc. stock logo
PFE
Pfizer
3.4297 of 5 stars
4.23.05.04.62.23.31.9
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Moderna, Inc. stock logo
MRNA
Moderna
2.36
Hold$179.1342.93% Upside
AbbVie Inc. stock logo
ABBV
AbbVie
2.43
Hold$163.4013.92% Upside
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.40
Hold$79.4320.90% Upside
GSK plc stock logo
GSK
GSK
2.09
Hold$1,576.884,378.49% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$173.009.16% Upside
McKesson Co. stock logo
MCK
McKesson
2.78
Moderate Buy$430.178.12% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.70
Moderate Buy$120.755.92% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.31
Hold$47.3329.75% Upside
XPH
SPDR S&P Pharmaceuticals ETF
0.00
N/AN/AN/A

Current Analyst Ratings

Latest Pharmaceutical Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2023
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
5/12/2023
McKesson Co. stock logo
MCK
McKesson
Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$430.00 ➝ $450.00
5/11/2023
Pfizer Inc. stock logo
PFE
Pfizer
Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$38.00
5/9/2023
McKesson Co. stock logo
MCK
McKesson
58.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMaintains
5/9/2023
McKesson Co. stock logo
MCK
McKesson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$450.00 ➝ $470.00
5/9/2023
McKesson Co. stock logo
MCK
McKesson
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$450.00 ➝ $475.00
5/9/2023
McKesson Co. stock logo
MCK
McKesson
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$376.00 ➝ $390.00
5/9/2023
McKesson Co. stock logo
MCK
McKesson
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$415.00 ➝ $420.00
5/5/2023
Moderna, Inc. stock logo
MRNA
Moderna
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$185.00 ➝ $153.00
5/5/2023
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$168.00 ➝ $170.00
5/5/2023
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$41.00 ➝ $39.00
(Data available from 5/18/2020 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Moderna, Inc. stock logo
MRNA
Moderna
$19.26B2.48$22.79 per share5.50$49.48 per share2.53
AbbVie Inc. stock logo
ABBV
AbbVie
$58.05B4.36$18.73 per share7.66$7.54 per share19.02
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$45.85B3.01$12.35 per share5.32$15.18 per share4.33
GSK plc stock logo
GSK
GSK
$36.28B1.99$4.30 per share8.18$6.71 per share5.25
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.94B4.34$12.94 per share12.25$27.27 per share5.81
McKesson Co. stock logo
MCK
McKesson
$276.71B0.19$32.37 per share12.29($10.99) per share-36.20
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$59.28B4.88$8.88 per share12.84$18.49 per share6.17
Pfizer Inc. stock logo
PFE
Pfizer
$92.95B2.22$7.51 per share4.86$17.93 per share2.03
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Moderna, Inc. stock logo
MRNA
Moderna
$8.36B$11.5710.83N/AN/A31.77%25.87%18.75%8/2/2023 (Estimated)
AbbVie Inc. stock logo
ABBV
AbbVie
$11.84B$4.2333.9113.002.6113.37%153.92%16.91%8/4/2023 (Estimated)
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$6.33B$3.4319.158.201.3715.95%51.75%17.05%7/26/2023 (Estimated)
GSK plc stock logo
GSK
GSK
$18.50B$8.284.259.171.8347.85%43.27%8.55%7/26/2023 (Confirmed)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$17.94B$4.7833.1514.392.7213.22%36.13%14.66%7/18/2023 (Estimated)
McKesson Co. stock logo
MCK
McKesson
$3.56B$25.1115.8413.111.371.29%-234.22%5.89%8/2/2023 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$14.52B$5.1222.2713.482.0222.52%37.92%15.90%7/27/2023 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$31.37B$5.087.1810.731.2331.25%37.53%18.08%7/27/2023 (Estimated)
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/A10.11N/AN/AN/AN/AN/A

Latest Pharmaceutical Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/26/2023N/A
GSK plc stock logo
GSK
GSK
$0.84N/A-$0.84N/AN/AN/A
5/8/2023Q4 23
McKesson Co. stock logo
MCK
McKesson
$7.16$7.19+$0.03$8.67$67.94 billion$68.91 billion    
5/4/2023Q1 2023
Moderna, Inc. stock logo
MRNA
Moderna
-$1.77$0.19+$1.96$0.19$1.17 billion$1.86 billion    
5/2/2023Q1 2023
Pfizer Inc. stock logo
PFE
Pfizer
$1.00$1.23+$0.23$1.49$16.49 billion$18.28 billion    
4/27/2023Q1 2023
AbbVie Inc. stock logo
ABBV
AbbVie
$2.44$2.46+$0.02$4.79$12.23 billion$12.23 billion    
4/27/2023Q1 2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.98$2.05+$0.07$3.03$11.50 billion$11.34 billion    
4/27/2023Q1 2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$1.34$1.40+$0.06$1.69$13.81 billion$14.49 billion    
4/18/2023Q1 23
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.51$2.68+$0.17$5.39$23.61 billion$24.75 billion    
2/23/2023Q4 2022
Moderna, Inc. stock logo
MRNA
Moderna
$4.66$3.61-$1.05$3.61$5.02 billion$5.08 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
AbbVie Inc. stock logo
ABBV
AbbVie
$5.924.13%+9.16%139.95%51 Years
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.283.47%+9.24%66.47%16 Years
GSK plc stock logo
GSK
GSK
$1.343.81%N/A16.18%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.522.85%+5.87%94.56%62 Years
McKesson Co. stock logo
MCK
McKesson
$2.160.54%+8.08%8.60%15 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.922.56%+7.40%57.03%12 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.644.50%+3.31%32.28%12 Years
XPH
SPDR S&P Pharmaceuticals ETF
$0.671.65%N/AN/AN/A

Latest Pharmaceutical Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2023
GSK plc stock logo
GSK
GSK
quarterly$0.34755.6%5/18/20235/19/20237/13/2023
4/27/2023
McKesson Co. stock logo
MCK
McKesson
quarterly$0.540.6%5/31/20236/1/20237/3/2023
4/26/2023
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.414.25%5/11/20235/12/20236/9/2023
4/18/2023
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Quarterly$1.192.96%5/22/20235/23/20236/6/2023
3/3/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.573.3%4/6/20234/10/20235/1/2023
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Moderna, Inc. stock logo
MRNA
Moderna
0.04
3.46
3.26
AbbVie Inc. stock logo
ABBV
AbbVie
4.46
0.96
0.82
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
1.10
1.42
1.28
GSK plc stock logo
GSK
GSK
1.47
0.95
0.69
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.07
0.85
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.51
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.60
1.44
1.19
Pfizer Inc. stock logo
PFE
Pfizer
0.31
1.37
1.11
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Moderna, Inc. stock logo
MRNA
Moderna
63.11%
AbbVie Inc. stock logo
ABBV
AbbVie
67.71%
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
75.51%
GSK plc stock logo
GSK
GSK
13.15%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
67.94%
McKesson Co. stock logo
MCK
McKesson
85.23%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
72.89%
Pfizer Inc. stock logo
PFE
Pfizer
67.62%
XPH
SPDR S&P Pharmaceuticals ETF
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Moderna, Inc. stock logo
MRNA
Moderna
3,900381.21 million321.36 millionOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.76 billion1.76 billionOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,3002.10 billion2.10 billionOptionable
GSK plc stock logo
GSK
GSK
69,4002.05 billion1.84 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
155,8002.60 billion2.59 billionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000135.60 million135.32 millionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
69,0002.54 billion2.53 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.65 billion5.64 billionOptionable
XPH
SPDR S&P Pharmaceuticals ETF
N/A4.60 millionN/AOptionable

Pharmaceutical Stocks Headlines

SourceHeadline
When Spdr S&p Pharmaceuticals ($XPH) Moves Investors should ListenWhen Spdr S&p Pharmaceuticals ($XPH) Moves Investors should Listen
marketwatch.com - April 12 at 3:10 PM
XPH SPDR S&P Pharmaceuticals ETFXPH SPDR S&P Pharmaceuticals ETF
seekingalpha.com - March 22 at 7:10 PM
SPYV: How Microsoft And Amazon Changed The S&P 500 Value IndexSPYV: How Microsoft And Amazon Changed The S&P 500 Value Index
seekingalpha.com - January 3 at 1:19 PM
Eli Lilly: Right Industry, Wrong PriceEli Lilly: Right Industry, Wrong Price
seekingalpha.com - December 27 at 2:36 PM
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1940SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1940
msn.com - December 19 at 5:47 PM
SPDR S&P 500 ESG ETF declares quarterly distribution of $0.1728SPDR S&P 500 ESG ETF declares quarterly distribution of $0.1728
msn.com - December 16 at 2:04 PM
XPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically UnattractiveXPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically Unattractive
seekingalpha.com - November 13 at 3:57 AM
Chevron, Uber Technologies, And A Way To Bet Against The Big Guys Are CNBCs Final TradesChevron, Uber Technologies, And A Way To 'Bet Against The Big Guys' Are CNBC's 'Final Trades'
msn.com - November 2 at 7:47 PM
Discerning Dealmaking: Caution Flag Still Raised in Biopharma M&A RaceDiscerning Dealmaking: Caution Flag Still Raised in Biopharma M&A Race
pharmexec.com - October 11 at 7:03 PM
MDYG SPDR S&P 400 Mid Cap Growth ETFMDYG SPDR S&P 400 Mid Cap Growth ETF
seekingalpha.com - October 1 at 6:13 AM
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1320SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1320
seekingalpha.com - September 21 at 4:56 AM
Drug ETFs Likely Winners of Health LawDrug ETFs Likely Winners of Health Law
thestreet.com - September 7 at 7:04 PM
Obamacare Still Sickly, After All These YearsObamacare Still Sickly, After All These Years
thestreet.com - September 5 at 11:22 PM
When Spdr S&p Biotech (XBI) Moves Investors should ListenWhen Spdr S&p Biotech (XBI) Moves Investors should Listen
news.stocktradersdaily.com - August 24 at 7:51 AM
SPDR S&P Pharmaceuticals ETF NewsSPDR S&P Pharmaceuticals ETF News
thestreet.com - July 2 at 9:37 PM
Gordon Pape’s mailbag: Pharma ETFs, tax losses, undeclared capital gains and other investing questionsGordon Pape’s mailbag: Pharma ETFs, tax losses, undeclared capital gains and other investing questions
theglobeandmail.com - May 24 at 10:36 AM
In a Sick Market, Can Pharmas Help?In a Sick Market, Can Pharmas Help?
realmoney.thestreet.com - May 3 at 10:08 AM
12.8% of XPH Holdings Seeing Recent Insider Buys12.8% of XPH Holdings Seeing Recent Insider Buys
nasdaq.com - April 27 at 12:36 PM
Insiders Buy the Holdings of XPH ETFInsiders Buy the Holdings of XPH ETF
nasdaq.com - March 18 at 6:12 PM
Viatris stands out amid selloff in generic drugmakersViatris stands out amid selloff in generic drugmakers
seekingalpha.com - March 5 at 2:40 PM
Is SPDRSP PHARMA (XPH) a Strong ETF Right Now?Is SPDRSP PHARMA (XPH) a Strong ETF Right Now?
nasdaq.com - November 15 at 3:10 PM
Thursdays ETF with Unusual Volume: XPHThursday's ETF with Unusual Volume: XPH
nasdaq.com - November 4 at 4:25 PM
Will the Pfizer share price look healthy after earnings?Will the Pfizer share price look healthy after earnings?
cmcmarkets.com - July 28 at 10:36 AM
First Trust Takes New Buffered ETF AngleFirst Trust Takes New Buffered ETF Angle
etf.com - July 16 at 12:35 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Moderna logo

Moderna

NASDAQ:MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
AbbVie logo

AbbVie

NYSE:ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Bristol-Myers Squibb logo

Bristol-Myers Squibb

NYSE:BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
GSK logo

GSK

NYSE:GSK
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women's Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
McKesson logo

McKesson

NYSE:MCK
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products, provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices, and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in European countries and Canada. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS segment br
Merck & Co., Inc. logo

Merck & Co., Inc.

NYSE:MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

SPDR S&P Pharmaceuticals ETF

NYSEARCA:XPH
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Key Points

  • Investing in the pharmaceutical industry can come with major risks alongside the potential for large profits. 
  • Consider beginning investing in major pharma and biotech companies before moving onto smaller, more volatile stocks. 
  • Research individual companies and consider factors such as the company's financial health, product pipeline and regulatory environment before investing.

Pharmaceutical research and development firms represent some of the most important companies in the United States. Investing in pharmaceutical companies can provide investors with a wide range of value growth opportunities, especially if the company issuing the underlying investment is on track to showcase a new development or successful trial results. 

But how do I invest in pharmaceuticals, and which companies are worth the investment? 

Retail investors can invest in pharmaceutical companies by purchasing shares of pharmaceutical stock traded on major exchanges. While investing in medical stocks is the same as any other major assets, research is fundamental. Read on to learn more about how to invest in pharmaceutical companies and how to research investment options. 

Overview of the Pharmaceutical Industry

Pharmaceutical companies research, develop and manufacture drugs and other pharmaceutical products to treat diseases and other medical conditions. These companies invest heavily in scientific research and development to create new drugs and improve existing drugs and technologies.

How do pharmaceutical companies make money? These companies earn money by developing and selling novel and safe drugs produced in the company's proprietary in-house lab processes. Pharmaceutical companies employ scientists, researchers and other professionals who work to discover new compounds, study their safety and efficacy and develop them into commercial products. They then conduct pre-clinical and clinical trials to test the safety and effectiveness of drugs. They submit their findings to regulatory agencies, such as the Food and Drug Administration (FDA), for approval.

Once approved, pharmaceutical companies manufacture and distribute drugs to healthcare providers and patients, often through partnerships with pharmacies and other healthcare organizations. These companies also use marketing and advertising to promote their products to healthcare providers and consumers.

What to Know about Pharmaceutical Companies

There are a few major sectors of the pharmaceutical industry that you'll want to be aware of when you select assets to invest in. Choosing investments from multiple types of companies can provide investors with exposure to both major names in pharmaceuticals and value pharmacy stocks for big gains

  • Large pharmaceutical companies: These are the largest and most established pharmaceutical companies, with significant resources and global reach. They invest heavily in research and development. They typically have a broad range of products that include novel compounds developed by company teams, which may or may not be patented. Companies in this sector include Johnson & Johnson (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE).
  • Generic drug companies: Generic drug companies specialize in producing and marketing generic versions of branded drugs that have lost patent protection. They often have lower costs than branded drug manufacturers and may be able to offer their products at a lower price. Examples of companies in this sector include Teva Pharmaceutical Industries (NYSE: TEVA) and Dr. Reddy's Laboratories (NYSE: RDY)
  • Biotech companies: Biotech-focused companies focus on developing new drugs and therapies based on biological processes and technologies, such as gene therapy, monoclonal antibodies and cell therapy. Browse a list of some of the best biotech stocks to buy
  • Medical device companies: Medical device companies develop and manufacture medical devices, such as surgical instruments, implantable devices and diagnostic equipment. Examples of companies in this sector include Medtronic PLC (NYSE: MDT) and Abbott Laboratories (NYSE: ABT).

Browse a complete list of healthcare stocks on MarketBeat

how to invest in pharmaceutical companies

How to Evaluate Pharmaceutical Companies for Investment 

Evaluating pharmaceutical companies for investment requires commitment and research. The following are a few key metrics to consider when investing in pharmaceuticals.

Step 1: Choose a list of companies to investigate.

The first step to researching pharmaceutical companies is to narrow down your list of contenders from the thousands of pharma companies trading on the market. If you're new to investing, start by examining the largest players in the pharma sphere. MarketBeat's healthcare stocks list is a great resource; you can search by total market capitalization. 

Step 2: Take a look at the financials.

After narrowing down your list, explore each company's financial information. Publicly traded companies make their debt, cash reserves, profitability and P/E ratios accessible to retail investors. You can access this information through each company's website or a stock information database like the one available from MarketBeat. Look for companies with a history of positive revenue growth and stable debt management. 

Step 3: Examine product pipelines.

After identifying stable companies with their financials in order, explore the products that the company is currently developing. Most pharmaceutical companies will issue a press release each time a drug or device in development reaches a new testing phase. Look at each company's current website to view drugs being developed and learn more about which stage of testing each product is in. Consider investing in companies with products in late release stages or which showcase new and patented compounds. 

Step 4: Take a look at the overall market.

Finally, examine broader market trends that could impact the pharmaceutical industry. This includes analyzing demographic trends, healthcare policy changes and consumer behavior shifts. Think about how the companies' products you just researched will fit into this shifting landscape. 

How to Invest in Pharmaceutical Companies

Investing in pharmaceutical companies follows the same basic principles as investing in any other type of publicly-traded companies. Use the following steps to add pharmaceutical companies and the top biotech stocks to your portfolio. 

Step 1: Open a brokerage account.

Once you've identified a pharmaceutical company to invest in, you must choose a broker. A brokerage account is a type of investing account you can use to buy and sell shares of stock as a retail investor. Several online brokers offer quick account signups for retail investors, with popular options including Charles Schwab, Robinhood and Webull. 

After choosing a broker, open a brokerage account and fund it with money to invest. You can transfer funds from your bank account using a direct wire transfer or use a credit or debit card to make a deposit. 

Step 2: Place an order.

Search for the company's ticker using your brokerage account to access the order page. Place a buy order for the number of shares you want to add to your portfolio. If you have a set purchase share price, use a limit order to lock in the rate and the number of shares. If not, you can use a market order to buy a predetermined number of shares at the current market price. 

Some brokers also allow you to buy in dollars rather than shares using a market order. If the number of shares you purchase doesn't reach an even number, your broker will use fractional shares to complete the order. This can be useful for casual investors looking for a faster way to invest long-term. 

Step 3: Monitor your investments.

After buying shares, it's essential to monitor your investments regularly. Keep track of the stock's performance and any news or developments that could affect its value. Check your investments multiple times daily if you're using a short-term trading strategy like shorting or scalping. 

Step 4: Consider expanding and diversifying.

Investing in pharmaceutical companies carries risks, so it's important to consider diversifying your portfolio. This means investing in various companies and industries to spread out your risk.

Pros and Cons of Investing in Pharmaceuticals

Be sure to consider both the pros and cons of pharmaceutical companies before investing, as these companies may carry higher levels of risk. 

Pros

Check out some of the benefits of investing in pharmaceuticals:

  • Potential for high returns: Successful pharmaceutical companies can offer high returns on investment, especially if they develop a blockbuster drug. If you can buy into a pharmaceutical developer at a low cost and the company releases a successful product, you could see higher profits when compared to low-volatility options like consumer staples. 
  • Stable demand for products: The demand for healthcare products and services remains relatively stable, providing a more stable investment than other industries. While individual stocks can be risky investments, you can mitigate your risk by investing in a pharmaceutical ETF. 

Cons

Now, the downsides: 

  • Higher risk of financial mismanagement: Developing a new drug can be a costly and time-consuming process. Companies may spend millions or even billions of dollars on research and development without guaranteeing success. This can lead to massive losses in share prices and, in some extreme cases, delisting. 
  • Dependence on regulatory approval: Pharmaceutical companies are subject to regulatory approval, which can be lengthy and uncertain. A delay or rejection in getting a new drug to market can significantly impact the company's financial performance.
  • Patent expirations: Patents on successful drugs eventually expire, which can lead to increased competition from generic drug makers and declining revenues.

Future of the Pharmaceutical Industry

The pharmaceutical industry is expected to continue to grow and evolve in the coming years, especially as millennials and Gen Xers reach middle age. Genomics and other technologies are making it possible to develop drugs tailored to an individual's unique genetic makeup, which may lead to an increased focus on personalized medicine.

In recent years, the pharmaceutical industry has been subject to increased levels of scrutiny by both regulators and consumers alike. This may lead to delays and increased costs for drug development, adding another layer of risk to investors in the pharmaceutical industry, and is expected to continue in coming years. 

Consider the Risks of the Pharmaceutical Industry

Overall, investing in pharmaceutical companies can offer high potential rewards but also carries high risks. Before investing in pharmaceutical companies, it's important to carefully research each company's financials and history of successful drug trials. As a new investor, consider sticking with the top 10 world pharma companies before branching out to smaller, more risky operations. 

FAQs

Learn a little more about big pharma companies and their competitors using the sections below. 

How do you invest in the pharmaceutical industry?

To invest in the pharmaceutical industry, you can buy stocks of individual pharmaceutical companies or invest in exchange-traded funds that track the industry's performance. It's important to research individual companies and consider factors such as the company's financial health, product pipeline and regulatory environment before investing.

Which pharmaceutical company is best to invest in?

The pharmaceutical companies that best complement your portfolio may vary depending on your investing goals. For example, if you're a long-term investor looking towards retirement, choose major names like Pfizer and Johnson & Johnson. If you're a short-term trader employing an active strategy, smaller and more volatile options may better suit your needs. 

What should you look for when investing in the pharmaceutical industry?

When investing in the pharmaceutical industry, some important factors include the company's financial health, product pipeline and regulatory environment. Look for companies with a strong balance sheet, consistent revenue growth and a diversified product pipeline that includes both new and established products.

My Account -